三一生物科技 TRIB 深 滬
已收盤 05-22 16:00:00 美东时间
0.602
-0.023
-3.70%
華盛通- 最 高0.62
- 今 開0.62
- 成交量 4.37万股
- 最 低 0.6001
- 昨 收 0.6251
- 總市值 1219.10万
- 52周最高 3.44
- 市盈率 靜 --
- 換手率 0.22%
- 52周最低 0.5012
- 委 比 97.61%
- 總股本 2025.09万
- 歷史最高 139.20
- 量 比 0.33
- 振 幅 3.18%
- 歷史最低 0.48
- 每 手 1
- 風險率 0.25%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Why Kyverna Therapeutics Shares Are Trading Higher By Over 25%; Here Are 20 Stocks Moving Premarket
Kyverna Therapeutics Inc (NASDAQ: KYTX) shares rose 25.8% in pre-market trading after positive trial results for miv-cel. Other gainers include HCAI, ELPW, and ALP.
04-22 17:31
Trinity Biotech Announces Successful Clinical Test Results For New Prostate Cancer Test AI-Incorporated Algorithm
The performance of the upgraded test was evaluated in a comprehensive clinical study involving approximately 750 patient samples, representing a substantially larger and more ethnically diverse cohort than EpiCapture's
03-23 21:26
Trinity Biotech Expects Q4 Revenue Range ~$11.5M - $12.5M
Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced an update on its trading
03-10 19:51
Trinity Biotech Receives Nasdaq Noncompliance Notice
Trinity Biotech plc (NASDAQ:TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, received notice on February 11, 2026 from the
02-14 06:12
Trinity Biotech Obtains Full Regulatory Approval For The Commencement Of Upstream Manufacturing Activities For Its Flagship WHO Prequalified Uni-Gold HIV Rapid Test Under The Company's Offshored And Outsourced Production Model
Trinity Biotech plc (NASDAQ:TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced it has now received full
02-11 02:33
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Trinity Biotech (NASDAQ:TRIB) stock moved upwards by 54.7% to $1.38 du...
2025-12-24 01:05
Why Is Trinity Biotech Stock Soaring Tuesday?
Trinity Biotech (NASDAQ: TRIB) surged on Tuesday due to a large HIV testing order and balance-sheet restructuring.
2025-12-23 22:59
Trinity Biotech shares are trading higher after the company announced it was awarded an order for 9 million TrinScreen HIV tests.
Trinity Biotech shares are trading higher after the company announced it was aw...
2025-12-23 20:34
Trinity Biotech Expands Global Rollout Of Next-Generation HbA1c Column System
Company advances its mission to deliver next-generation diabetes management solutions and expand global market penetrationNext-generation column technology enhances efficiency, expands recurring revenue potential, and
2025-12-15 22:19
Trinity Biotech Partners With Unnamed Bioinformatics Firm To Conduct Analysts On Clinical Study Data For EpiCapture Epigenetic Liquid Biopsy Test To Monitor Prostate Cancer
Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced a strategic collaboration with a
2025-11-14 22:06
